Molly Henderson
Overview
Molly Henderson received an average of $2M in total compensation, including $428K in salary, at Phathom Pharmaceuticals between 2022 and 2023. Molly Henderson also received an average of $505K at Advaxis between 2019 and 2020 and $1M at UroGen Pharma Ltd. in 2020.
Source: SEC filings on April 12, 2024, April 13, 2023, April 28, 2021, and April 21, 2021.
Related executives
We found 26 more executives who work or worked at Phathom Pharmaceuticals, Advaxis, andUroGen Pharma Ltd..
Terrie Curran
Phathom Pharmaceuticals
Chief Executive Officer
Azmi Nabulsi
Phathom Pharmaceuticals
Chief Operating Officer
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
Jason Smith
UroGen Pharma Ltd.
General Counsel
Don Kim
UroGen Pharma Ltd.
Chief Financial Officer
Kenneth Berlin
Advaxis
Chief Executive Officer
Andres Gutierrez
Advaxis
Chief Medical Officer
Igor Gitelman
Advaxis
Chief Financial Officer
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
Advaxis CEO Kenneth Berlin's 2020 pay jumps 21% to $1.2M
April 21, 2021